Antisoma Inc.
700 Technology Square
Suite 220
Cambridge
Massachusetts
W4 5YF
United States
Tel: 617-252-6100
Fax: 617-252-6101
Website: http://www.antisoma.com/
161 articles about Antisoma Inc.
-
The iQ Group Global secures worldwide license for Harvard University’s eRapid technology for at-home diagnostic testing
3/8/2022
Antisoma Therapeutics Pty. Ltd. announced it has received a worldwide license from Harvard’s Office of Technology Development to commercialize diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University, with exclusivity in the fields of respiratory viral illnesses, cancer, and immune/allergic disease.
-
Permanent Headcount Down to Nil at Antisoma Inc.
5/24/2011
-
Biothera Acquires MUC1 Anti-Cancer Monoclonal Antibody From Antisoma PLC
3/10/2011
-
Antisoma PLC's CEO and Finance Director Leave After Drug Setbacks
3/1/2011
-
Antisoma PLC Reports Half-Year Results for the Six Months to 31 December 2010
2/8/2011
-
Antisoma PLC's Leukemia Drug Fails at Phase III
2/1/2011
-
Antisoma PLC ASH Meeting Update
12/2/2010
-
Antisoma PLC's AS1413 Phase III AML Data Now Expected Q1 2011
11/30/2010
-
Antisoma PLC to Present at Piper Jaffray Health Care Conference on Tuesday, November 30
11/24/2010
-
Novartis AG Stops Lung Cancer Drug Trial of ASA404, Developed in Partnership with Antisoma PLC, Books $120 Million Charge
11/11/2010
-
Antisoma PLC Awarded US Qualifying Therapeutic Discovery Project Grant Of USD 244K
11/8/2010
-
Antisoma PLC Interim Management Statement
10/13/2010
-
Antisoma PLC's Phase III Trial of AS1413 Completes Patient Enrollment
9/8/2010
-
Antisoma PLC's Phase III Trial of AS1413 Completes Patient Enrollment
9/8/2010
-
Antisoma PLC Annual Report and Accounts 2010
9/2/2010
-
Antisoma PLC to Present at Canaccord Global Growth Conference
8/6/2010
-
Antisoma PLC's Preliminary Results For The Year Ended 30 June 2010
7/29/2010
-
Antisoma PLC to present at 5th Annual Piper Jaffray Europe Healthcare Conference
6/21/2010
-
Antisoma PLC Announces AS1413 And AS1411 Presentations At EHA
6/14/2010
-
Antisoma PLC Announces Presentation At ASCO Of New Data Supporting AS1413 And AS1411
6/7/2010